Lupus News Today |
Tregitope Technology Could Become Autoimmune Treatment in Hands of Global Pharma Company
Lupus News Today EpiVax has licensed its Tregitope technology — a new approach to harnessing the power of regulatory T-cells in autoimmune diseases such as systemic lupus erythematosus (SLE) — to an undisclosed global pharmaceutical company. The license will allow … |
May 01, 2017 at 07:09PM
from
No comments:
Post a Comment